Cargando…

Integrating COPD care in Italy

Detalles Bibliográficos
Autor principal:	Calverley, Peter MA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050223/ https://www.ncbi.nlm.nih.gov/pubmed/24917930 http://dx.doi.org/10.1186/2049-6958-9-26

Ejemplares similares

COPD in the time of COVID-19
por: Calverley, Peter M.A.
Publicado: (2021)

Guidance for the Better Care of Patients with Chronic Obstructive Pulmonary Disease
por: Calverley, Peter M. A.
Publicado: (2020)

ACO (Asthma–COPD Overlap) Is Independent from COPD: The Case Against
por: Calverley, Peter M. A., et al.
Publicado: (2021)

Roflumilast: a review of its use in the treatment of COPD
por: Wedzicha, Jadwiga A, et al.
Publicado: (2016)

Angels Dancing on the Tip of a Needle: Interpreting Clinical Trials in Chronic Obstructive Pulmonary Disease
por: Calverley, Peter
Publicado: (2020)

Reigniting the TORCH: Chronic Obstructive Pulmonary Disease Mortality and Inhaled Corticosteroids Revisited
por: Calverley, Peter
Publicado: (2021)

Lessons from the North: CanCOLD, Exercise, and Chronic Obstructive Pulmonary Disease
por: Calverley, Peter
Publicado: (2022)

Meeting the GOLD Standard: COPD Treatment in the UK Today
por: Calverley, P.M.A.
Publicado: (2019)

Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation
por: Calverley, Peter MA, et al.
Publicado: (2019)

Defining Airflow Obstruction: More Data, Further Clarity
por: Calverley, Peter M. A.
Publicado: (2020)

A STAR Is Born: A New Approach to Assessing Chronic Obstructive Pulmonary Disease Severity
por: Calverley, Peter M. A.
Publicado: (2023)

Indices and COPD
por: Howard, Peter
Publicado: (2010)

Enhancing the diagnosis and management of COPD in Primary care
por: Partridge, Martyn R
Publicado: (2014)

Eosinophils in COPD: why should I care?
por: Fernandes, Frederico Leon Arrabal
Publicado: (2016)

The severity of airways obstruction as a determinant of treatment response in COPD
por: Calverley, Peter MA, et al.
Publicado: (2006)

Chronic obstructive pulmonary disease and exacerbations: Patient insights from the global Hidden Depths of COPD survey
por: Barnes, Neil, et al.
Publicado: (2013)

Determinants of exacerbation risk in patients with COPD in the TIOSPIR study
por: Calverley, Peter MA, et al.
Publicado: (2017)

Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD
por: Calverley, Peter MA, et al.
Publicado: (2018)

Usefulness of the COPD assessment test (CAT) in primary care
por: Langhammer, Arnulf, et al.
Publicado: (2013)

Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR(®) trial
por: Wise, Robert A, et al.
Publicado: (2018)

Genetics, Chronic Obstructive Pulmonary Disease, and the Arrow of Time
por: Calverley, Peter M. A., et al.
Publicado: (2019)

Understanding the People Excluded from Chronic Obstructive Pulmonary Disease Clinical Trials
por: Krishnan, Jamuna K., et al.
Publicado: (2022)

Intermediate Care in Italy: Addressing the Challenges and Opportunities for Person-Tailored Care
por: Boccardi, Virginia, et al.
Publicado: (2023)

Factors associated with change in exacerbation frequency in COPD
por: Donaldson, Gavin C, et al.
Publicado: (2013)

Palliative care in COPD patients: A challenge in modern medicine
por: Lobato, Salvador Díaz, et al.
Publicado: (2015)

Advance care planning in severe COPD: it is time to engage with the future
por: Andreas, Stefan, et al.
Publicado: (2018)

Spotlight on primary care management of COPD: Electronic health records
por: Harries, Timothy H, et al.
Publicado: (2021)

Reduction of exacerbations by the PDE4 inhibitor roflumilast - the importance of defining different subsets of patients with COPD
por: Rennard, Stephen I, et al.
Publicado: (2011)

The association of tidal EFL with exercise performance, exacerbations, and death in COPD
por: Aarli, Bernt Boegvald, et al.
Publicado: (2017)

Imaging and COPD
por: Hochhegger, Bruno
Publicado: (2015)

Women with COPD
por: McIvor, Emma R., et al.
Publicado: (2020)

Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study
por: Dal Negro, Roberto W., et al.
Publicado: (2017)

Assessment of COPD in primary care: new evidence supports use of the DOSE index
por: Sundh, Josefin, et al.
Publicado: (2013)

Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? the REACT study protocol
por: Calverley, Peter MA, et al.
Publicado: (2012)

Healthy behaviours and COPD
por: Annesi-Maesano, Isabella, et al.
Publicado: (2014)

Anxiety and depression in COPD
por: Salerno, Francesco G, et al.
Publicado: (2011)

Pulmonary Dysfunction in COPD
por: Spiropoulos, Kostas, et al.
Publicado: (2013)

COVID-19 and COPD
por: Leung, Janice M., et al.
Publicado: (2020)

Oxidative Stress in COPD
por: Magallón, María, et al.
Publicado: (2019)

COPD & COVID-19
por: Halpin, David M.G., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_92eubai6hugvta00rh02olkuv3